Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyery Kim

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Cancer Research and Treatment|July 22, 2014
Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescentsHyery Kim, Eun Sil Park, Soo Hyun Lee, et al.
Journal of Korean Medical Science|March 1, 2017
Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 StudyKyung Nam Koh, Ho Joon Im, Hyery Kim, et al.
Pediatric Blood & Cancer|February 8, 2023
High-dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcomaSung Han Kang, Wanlim Kim, Jong Seok Lee, et al.
Hemasphere|June 18, 2025
Comparable outcomes for pediatric acute lymphoblastic leukemia patients receiving conditioning with total body irradiation or chemotherapy: A nationwide, Korean registry-based studyKyung Taek Hong, Jung Yoon Choi, Hyery Kim, et al.
Neuro-Oncology|July 8, 2024
Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibromaHyery Kim, Hee Mang Yoon, Eun Key Kim, et al.
Cancer Research and Treatment|January 10, 2021
Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in KoreaJung Yoon Choi, Che Ry Hong, Kyung Taek Hong, et al.
Genes|June 2, 2021
Genetic Confirmation and Identification of Novel Variants for Glanzmann Thrombasthenia and Other Inherited Platelet Function Disorders: A Study by the Korean Pediatric Hematology Oncology Group (KPHOG)Eu Jeen Yang, Ye Jee Shim, Heung Sik Kim, et al.
The Korean Journal of Hematology|July 12, 2012
Clinical and hematologic manifestations in patients with Diamond Blackfan anemia in KoreaSoon-Ki Kim, Hyo-Seop Ahn, Hee-Jo Back, et al.
Cancer Research and Treatment|May 17, 2018
Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer PatientsHyery Kim, Hyoung Jin Kang, Kyung Duk Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2016
Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective StudiesHyoung Jin Kang, Kyung Taek Hong, Ji Won Lee, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Cancer Research and Treatment|July 22, 2014
Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescentsHyery Kim, Eun Sil Park, Soo Hyun Lee, et al.
Journal of Korean Medical Science|March 1, 2017
Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 StudyKyung Nam Koh, Ho Joon Im, Hyery Kim, et al.
Pediatric Blood & Cancer|February 8, 2023
High-dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcomaSung Han Kang, Wanlim Kim, Jong Seok Lee, et al.
Hemasphere|June 18, 2025
Comparable outcomes for pediatric acute lymphoblastic leukemia patients receiving conditioning with total body irradiation or chemotherapy: A nationwide, Korean registry-based studyKyung Taek Hong, Jung Yoon Choi, Hyery Kim, et al.
Neuro-Oncology|July 8, 2024
Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibromaHyery Kim, Hee Mang Yoon, Eun Key Kim, et al.
Cancer Research and Treatment|January 10, 2021
Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in KoreaJung Yoon Choi, Che Ry Hong, Kyung Taek Hong, et al.
Genes|June 2, 2021
Genetic Confirmation and Identification of Novel Variants for Glanzmann Thrombasthenia and Other Inherited Platelet Function Disorders: A Study by the Korean Pediatric Hematology Oncology Group (KPHOG)Eu Jeen Yang, Ye Jee Shim, Heung Sik Kim, et al.
The Korean Journal of Hematology|July 12, 2012
Clinical and hematologic manifestations in patients with Diamond Blackfan anemia in KoreaSoon-Ki Kim, Hyo-Seop Ahn, Hee-Jo Back, et al.
Cancer Research and Treatment|May 17, 2018
Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer PatientsHyery Kim, Hyoung Jin Kang, Kyung Duk Park, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2016
Improved Outcome of a Reduced Toxicity-Fludarabine, Cyclophosphamide, plus Antithymocyte Globulin Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia: Comparison of 2 Multicenter Prospective StudiesHyoung Jin Kang, Kyung Taek Hong, Ji Won Lee, et al.
Pageof 11